Shake-up at AstraZeneca sees drugs giant slash 700 UK jobs

Chancellor's constituency is hit as company closes R&D facility in Cheshire

AstraZeneca is cutting 700 jobs in the UK, most of them in George Osborne's Tatton constituency, as part of a global restructuring that will result in a total of about 1,600 redundancies.

In a move that angered unions and caused embarrassment for the Chancellor ahead of tomorrow's Budget, the pharmaceuticals group announced it would close its research and development operation at Alderley Park, Cheshire. About 500 jobs will be lost there over the next three years, and a further 1,600 positions will move to a new research and development centre in Cambridge. A further 150 UK jobs will be lost outside Alderley Park in the restructure, bringing total UK redundancies to more than 10 per cent of the company's existing workforce of 6,700 in Britain spread over eight sites. Some 700 non-R&D jobs will remain at Alderley Park. Another 650 jobs will go in the US.

The shake-up will prompt a $1.4bn (£930m) charge and also see AstraZeneca's headquarters move from London to Cambridge.

AstraZeneca sought to soothe its staff by announcing a £330m investment in its new R&D site in Cambridge, but unions still reacted angrily.

Unite's national officer Linda McCulloch said: "Staff will be shell-shocked by this announcement. AstraZeneca's decision to relocate over a thousand jobs to Cambridge is a massive blow for the North-west. The region desperately needs this highly skilled workforce – they make a huge contribution to the economy and to the community."

The GMB's national officer Allan Black added: "This is disastrous news for the UK, and the North-west in particular."

AstraZeneca's chief executive Pascal Soriot put a positive spin on the announcement, saying: "The changes we are proposing represent an exciting and important opportunity to put science at the heart of everything we do because our long-term success depends on improving R&D productivity and achieving scientific leadership."

Drugs that account for more than 40 per cent of AstraZeneca's sales, such as ulcer and heartburn treatment Nexium, will lose their patent protection by the end of next year. Furthermore, the patent losses will continue beyond next year, with the group's best-selling drug, Crestor, used to combat cholesterol, set to lose its US patent protection in 2016.

This will open some of AstraZeneca's biggest-selling drugs to competition from low-cost rivals and prompted the group to warn in January that its sales and profits would fall sharply this year. Mr Soriot, who took over the chief executive's reins from David Brennan last year after a series of drug-development setbacks, said at the time that internal R&D, rather than takeovers, were the key to growth.

In October, AstraZeneca suspended its share buyback programme to give it more money to invest in the business. Mr Soriot acknowledged the difficulties his restructuring plan would cause in the UK and pledged to make the process as smooth as possible.

"I recognise our plans will have a significant impact on many of our people at our sites in Cheshire and London and the surrounding communities. We are committed to treating all our employees with respect and fairness as we navigate this period of change," he said.

The restructuring will focus AstraZeneca's research in three centres: Gaithersburg, Maryland in the US, Molndal in Sweden and Cambridge.

Start your day with The Independent, sign up for daily news emails
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Financial Adviser

£20000 - £60000 per annum: Recruitment Genius: Are you recently QCA Level 4 qu...

SThree: Graduate Recruitment Resourcer

£20000 - £22500 per annum + OTE £30K: SThree: SThree Group have been well esta...

Guru Careers: Application Support Analyst / 1st Line Support

£25 - 30k: Guru Careers: We are seeking an Application Support Analyst / 1st L...

Guru Careers: .NET Developer / Web Developer

£45K - £55K (DOE) + Benefits: Guru Careers: We are seeking a full stack .NET D...

Day In a Page

Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

Not even the 'putrid throat' could stop the Ross Poldark swoon-fest'

How a costume drama became a Sunday night staple
Miliband promises no stamp duty for first-time buyers as he pushes Tories on housing

Miliband promises no stamp duty for first-time buyers

Labour leader pushes Tories on housing
Aviation history is littered with grand failures - from the the Bristol Brabazon to Concorde - but what went wrong with the SuperJumbo?

Aviation history is littered with grand failures

But what went wrong with the SuperJumbo?
Fear of Putin, Islamists and immigration is giving rise to a new generation of Soviet-style 'iron curtains' right across Europe

Fortress Europe?

Fear of Putin, Islamists and immigration is giving rise to a new generation of 'iron curtains'
Never mind what you're wearing, it's what you're reclining on

Never mind what you're wearing

It's what you're reclining on that matters
General Election 2015: Chuka Umunna on the benefits of immigration, humility – and his leader Ed Miliband

Chuka Umunna: A virus of racism runs through Ukip

The shadow business secretary on the benefits of immigration, humility – and his leader Ed Miliband
Yemen crisis: This exotic war will soon become Europe's problem

Yemen's exotic war will soon affect Europe

Terrorism and boatloads of desperate migrants will be the outcome of the Saudi air campaign, says Patrick Cockburn
Marginal Streets project aims to document voters in the run-up to the General Election

Marginal Streets project documents voters

Independent photographers Joseph Fox and Orlando Gili are uploading two portraits of constituents to their website for each day of the campaign
Game of Thrones: Visit the real-life kingdom of Westeros to see where violent history ends and telly tourism begins

The real-life kingdom of Westeros

Is there something a little uncomfortable about Game of Thrones shooting in Northern Ireland?
How to survive a social-media mauling, by the tough women of Twitter

How to survive a Twitter mauling

Mary Beard, Caroline Criado-Perez, Louise Mensch, Bunny La Roche and Courtney Barrasford reveal how to trounce the trolls
Gallipoli centenary: At dawn, the young remember the young who perished in one of the First World War's bloodiest battles

At dawn, the young remember the young

A century ago, soldiers of the Empire – many no more than boys – spilt on to Gallipoli’s beaches. On this 100th Anzac Day, there are personal, poetic tributes to their sacrifice
Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves

Follow the money as never before

Dissent is slowly building against the billions spent on presidential campaigns – even among politicians themselves, reports Rupert Cornwell
Samuel West interview: The actor and director on austerity, unionisation, and not mentioning his famous parents

Samuel West interview

The actor and director on austerity, unionisation, and not mentioning his famous parents
General Election 2015: Imagine if the leading political parties were fashion labels

Imagine if the leading political parties were fashion labels

Fashion editor, Alexander Fury, on what the leaders' appearances tell us about them
Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

Phumzile Mlambo-Ngcuka: Home can be the unsafest place for women

The architect of the HeForShe movement and head of UN Women on the world's failure to combat domestic violence